- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Syncom Formulations (India) Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting
12-02-2026 | 04:46 pm
12-02-2026 | 04:46 pm
SYNCOM FORMULATIONS' board approved financial results for the quarter and nine months ending Dec 31, 2025. Consolidated profit for Q3 rose to ₹18.91 Cr, while 9-month profit hit ₹51.26 Cr.
No comments yet. Be the first to comment!